派格生物医药-B：截至2025年12月31日止年度年度业绩公告

PegBio Co., Ltd. 2565 20251231 202512312024 (FIC)(BIC)2025 PB-11 9GLP-1 GLP-1PB-119202511 PB-119PB-1192026 I/II (IND) I. 20082T2DMNASHOIC II. 20251231INDPEG 20251231 PB-119 PB-119GLP-1T2DMPB-119202511 PB-119PB-119 PB-119 PB-119PB-119PB-1192026 PB-119 PB-119 PB-718GLP-1/GCG PB-718GLP-1(GCG)(MASH) PB-718PB-718IIb/IIaCTR20231655PB-718 Ib/IIaPB-718PB-718(MASH) PB-718PB-718 PB-718 PB-1902OIC PB-1902(OIC)OIC PB-1902PB-1902I(PK)(PD)PB-1902OICII PB-1902 PB-1902 PB-722GCG PB-722GCG20215FDAPB-72220235INDPB-722PB-722IND2026IPB-722PKPD2027II PB-722 PB-2301T2DMNASH PB-23012(T2DM)(NASH) PB-2301 PB-2301 PB-2301 PB-2309GLP-1/GIP/GCGT2DMNASH PB-2309GLP-1/GIP/GCG2(T2DM)(NASH) PB-2309 PB-2309 PB-2309 PB-2309 APGP6 APGP6(lean mass) APGP6 NAPGP6 APGP6 20251231 20252024123150.495.4 CMC 20251231CMCCMC10CMCCMC CDMOCMOCDMO 20251231 ®(PB-119)202511 PB-119 PB-119 PB-119 2024913PB-1192025331PB-1192025630 PB-11920256PB-119PB-119 2025123183141420251231HECTOR®(PEG) ®(PB-119)202511 PB-119PB-119 III. 20251231208.520241231283.4 PB-119NDAPB-119 20251231208.520241231283.474.9PB-119 2025123150.42024123195.445.0(i)2024123122.8(ii)PB-119 20251231143.320241231185.342.0(i)2024123140.2(ii)20255 202420251231183.4151.9 20251231151.920241231183.4 2025123197.920241231114.4 20251231498.92025122024123120.3 20251231467.52024123128.4439.1202512 2025123185.020241231100.015.0 2025123120241231 202512312.4%3.0%202412312.6%3.1% 2025123120.9%20241231176.6% 202412311.5202512318.6 202512315% (i)202344202026443.10%1.72025123121.7 (ii)2023921202481302026813.20%2.12025123132.3 5% 20251020251134,993,000 20251231 20251231 202512313.7 2025123127,0002024 20251231 20251231582024123164 12 IV. • ••PB-119PB-119 ••••••••• I. 2025123120241231 II. III. 2 C.2.1 2C.2.1Michael Min XU20085(i)(ii)(iii) IV. 3.212D.3XiangjunZHOU3.10(2)3.21 • ••••• 2025123120251231 V. 20251231 VI. 20251231 VII. 1.00H202551915.619,283,500231.8212.6 20251231 19.2(i)18(ii)1.2 202512 2 0 2 51 21 2H58.415,136,000HH58.41(i)H2025121264.9010%(ii)H62.887.11%299,993,760295,699,826 20251222 (1) (2)29.57(i) 12.59(ii)16.98 2025121420251222 VIII. 1.00H500H50H202633192026310 IX. 13.2013.2113.22 X.2025 ( www.pegbio.com )( www.hkexnews.hk )20251231 XI. 20251231 4 –– (208,547)(283,351) (208,547)(283,351) (208,362)(283,158)(185)(193) 1 (a) 20255H 1(c) (b) 20251231 (c) 21 123120252024 (i) (i) 3 (a) (b) (i) (i) (i)2025123117,627,000202444,379,0001,487,00020241,682,000 (ii)20251231652,00020243,198,000 4 (a) (i) 25% 20229100%20251231 (b) 4(a)(i) 5 (a) 208,362,0002024283,158,000378,383,0002024366,672,000 (b) 202512312024 6 9 2025 1.00 15 CDMO CMC CMO 12 Michael Min XU 2026323 (i)Michael Min XU(ii)Xiangjun ZHOU(iii)Jiancun ZHANG